Can we prevent congestive heart failure? Excerpts from a symposium.
作者信息
Francis G S
机构信息
Coronary Intensive Care Unit, Cleveland Clinic Foundation, Ohio 44195, USA.
出版信息
Clin Cardiol. 2000 Jul;23(7 Suppl 4):IV1-3. doi: 10.1002/clc.4960230702.
Abstract
摘要
相似文献
1
Can we prevent congestive heart failure? Excerpts from a symposium.我们能预防充血性心力衰竭吗？研讨会摘录。
Clin Cardiol. 2000 Jul;23(7 Suppl 4):IV1-3. doi: 10.1002/clc.4960230702.
2
3
[Angiotensin-converting enzyme inhibitors as first choice drugs in chronic congestive heart failure].血管紧张素转换酶抑制剂作为慢性充血性心力衰竭的首选药物
Pol Arch Med Wewn. 1992 Aug-Sep;88(2-3):165-70.
4
The renin-angiotensin-aldosterone system and heart failure.肾素-血管紧张素-醛固酮系统与心力衰竭。
Cardiol Clin. 2014 Feb;32(1):21-32, vii. doi: 10.1016/j.ccl.2013.09.002.
5
Aldosterone in congestive heart failure.充血性心力衰竭中的醛固酮
N Engl J Med. 2001 Dec 6;345(23):1689-97. doi: 10.1056/NEJMra000050.
6
Role of angiotensin-converting enzyme inhibitors in congestive heart failure.血管紧张素转换酶抑制剂在充血性心力衰竭中的作用。
Heart Lung. 1990 Sep;19(5 Pt 1):505-11.
7
Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭的肾素-血管紧张素系统特征
J Am Coll Cardiol. 2016 Dec 27;68(25):2912-2914. doi: 10.1016/j.jacc.2016.10.017.
8
Activated tissue renin-angiotensin systems add to the progression of heart failure.激活的组织肾素-血管紧张素系统会加重心力衰竭的进展。
Basic Res Cardiol. 1996;91 Suppl 2:85-90. doi: 10.1007/BF00795368.
9
10
The renin-angiotensin system in hypertension: an update.高血压中的肾素-血管紧张素系统：最新进展
Hosp Pract (Off Ed). 1990 Aug 15;25(8):71-81. doi: 10.1080/21548331.1990.11703984.
本文引用的文献
1
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.雷米普利对糖尿病患者心血管和微血管结局的影响：HOPE研究及MICRO-HOPE子研究结果。心脏结局预防评估研究组。
Lancet. 2000 Jan 22;355(9200):253-9.
2
ACE inhibition in cardiovascular disease.心血管疾病中的血管紧张素转换酶抑制作用。
N Engl J Med. 2000 Jan 20;342(3):201-2. doi: 10.1056/NEJM200001203420309.
3
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.血管紧张素转换酶抑制剂雷米普利对高危患者心血管事件的影响。
N Engl J Med. 2000 Jan 20;342(3):145-53. doi: 10.1056/NEJM200001203420301.
4
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.螺内酯对重度心力衰竭患者发病率和死亡率的影响。随机螺内酯评估研究调查组。
N Engl J Med. 1999 Sep 2;341(10):709-17. doi: 10.1056/NEJM199909023411001.
5
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
Eur Heart J. 1999 Aug;20(16):1182-90. doi: 10.1053/euhj.1998.1481.
6
Towards the better treatment of heart failure.迈向心力衰竭的更好治疗。
Eur Heart J. 1998 Oct;19 Suppl L:L36-42.
7
Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease.纤溶平衡、肾素-血管紧张素系统与动脉粥样硬化疾病
Eur Heart J. 1998 Jul;19 Suppl G:G9-12.
8
Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors.
Pharmacotherapy. 1998 May-Jun;18(3):588-99.
9
Prevention of worsening heart failure: future focus.
Eur Heart J. 1998 Feb;19 Suppl B:B47-53.
10
Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.雷米普利对急性前壁心肌梗死患者血浆纤溶平衡的影响。心脏研究调查组。
Circulation. 1997 Jul 15;96(2):442-7. doi: 10.1161/01.cir.96.2.442.
Zotero 插件